Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Hansen

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Cytotherapy|July 18, 2016
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21Morten Hansen, Özcan Met, Niels Bent Larsen, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2019
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesityPhilip Newsome, Sven Francque, Stephen Harrison, et al.
Frontiers in Immunology|December 27, 2016
Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-ChemokinesGertrud M Hjortø, Olav Larsen, Anne Steen, et al.
Frontiers in Immunology|February 10, 2017
Corrigendum: Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-ChemokinesGertrud M Hjortø, Olav Larsen, Anne Steen, et al.
Scientific Reports|November 8, 2017
Butyrate and propionate inhibit antigen-specific CD8<sup>+</sup> T cell activation by suppressing IL-12 production by antigen-presenting cellsClaudia Nastasi, Simon Fredholm, Andreas Willerslev-Olsen, et al.
Cancers|October 1, 2020
Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint BlockadeChristina Jensen, Dovile Sinkeviciute, Daniel Hargbøl Madsen, et al.
The Journal of Investigative Dermatology|September 28, 2012
Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusionMarco Donia, Morten Hansen, Sarah L Sendrup, et al.
Vaccine|December 4, 2012
Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapyMorten Hansen, Gertrud Malene Hjortø, Marco Donia, et al.
European Journal of Haematology|September 20, 2015
Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia veraCaroline H Riley, Marie K Brimnes, Morten Hansen, et al.
Oncoimmunology|September 14, 2016
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccineShamaila Munir Ahmad, Evelina Martinenaite, Morten Hansen, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Cytotherapy|July 18, 2016
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21Morten Hansen, Özcan Met, Niels Bent Larsen, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2019
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesityPhilip Newsome, Sven Francque, Stephen Harrison, et al.
Frontiers in Immunology|December 27, 2016
Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-ChemokinesGertrud M Hjortø, Olav Larsen, Anne Steen, et al.
Frontiers in Immunology|February 10, 2017
Corrigendum: Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-ChemokinesGertrud M Hjortø, Olav Larsen, Anne Steen, et al.
Scientific Reports|November 8, 2017
Butyrate and propionate inhibit antigen-specific CD8<sup>+</sup> T cell activation by suppressing IL-12 production by antigen-presenting cellsClaudia Nastasi, Simon Fredholm, Andreas Willerslev-Olsen, et al.
Cancers|October 1, 2020
Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint BlockadeChristina Jensen, Dovile Sinkeviciute, Daniel Hargbøl Madsen, et al.
The Journal of Investigative Dermatology|September 28, 2012
Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusionMarco Donia, Morten Hansen, Sarah L Sendrup, et al.
Vaccine|December 4, 2012
Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapyMorten Hansen, Gertrud Malene Hjortø, Marco Donia, et al.
European Journal of Haematology|September 20, 2015
Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F-positive essential thrombocythemia and polycythemia veraCaroline H Riley, Marie K Brimnes, Morten Hansen, et al.
Oncoimmunology|September 14, 2016
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccineShamaila Munir Ahmad, Evelina Martinenaite, Morten Hansen, et al.
Pageof 9